Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease.

In proteinuric glomerulopathies, the excess traffic of proteins into the renal tubule is a candidate trigger of interstitial inflammatory and immune events leading to progressive injury, and a key target for the renoprotective action of antiproteinuric drugs. Among proteins trafficked to the proximal tubule, the third component of complement (C3) can be activated locally and contribute to inflammation at sites of protein reabsorption. Experiments were performed in rats with renal mass reduction (RMR, 5/6 nephrectomy) with the following aims: (1) to study Ig (IgG) and complement deposition in proximal tubules, and interstitial macrophage infiltration and MHC class II expression at intervals after surgery by double immunofluorescence analysis; (2) to assess whether lisinopril (angiotensin-converting enzyme inhibitor [ACEi], 25 mg/L in the drinking water, from either day 1 or day 7) limited IgG and C3 accumulation and interstitial inflammation at day 30. In 7-d remnant kidneys, intracellular staining for both IgG and C3 was detectable in proximal tubules in focal areas; C3 was restricted to IgG-positive tubular cells, and there were no interstitial ED-1 macrophage and MHC II-positive cellular infiltrates. In 14-d and 30-d remnant kidneys, proximal tubular IgG and C3 staining was associated with the appearance of interstitial infiltrates that preferentially localized to areas of tubules positive for both proteins. RMR rats given ACEi had no or limited increases in levels of urinary protein excretion, tubular IgG, and C3 reactivity, and interstitial cellular infiltrates in kidneys at 30 d, even when ACEi was started from day 7 after surgery. These findings document that (1) in RMR, IgG and C3 accumulation in proximal tubular cells is followed by leukocyte infiltration and MHC II overexpression in the adjacent interstitium; (2) ACEi while preventing proteinuria limits both tubular accumulation of IgG and C3 and interstitial inflammation. The data suggest that ACE inhibition can be renoprotective by limiting the early abnormal protein traffic in proximal tubule and consequent deleterious effects of excess protein reabsorption, including the accumulation and local activation of complement as well as the induction of chemokines and endothelin genes known to promote interstitial inflammation and fibrosis.

[1]  G. Remuzzi,et al.  Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals. , 1999, Journal of the American Society of Nephrology : JASN.

[2]  Wuding Zhou,et al.  Apical proteins stimulate complement synthesis by cultured human proximal tubular epithelial cells. , 1999, Journal of the American Society of Nephrology : JASN.

[3]  G. Remuzzi,et al.  Pathophysiology of progressive nephropathies. , 1998, The New England journal of medicine.

[4]  G. Remuzzi,et al.  In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. , 1998, Journal of the American Society of Nephrology : JASN.

[5]  T. Koji,et al.  Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney. , 1998, Kidney international.

[6]  G. Remuzzi,et al.  Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. , 1998, Kidney international.

[7]  G. Remuzzi,et al.  Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes , 1998, BMJ.

[8]  阿部克成 Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney , 1998 .

[9]  T. Koji,et al.  Intraglomerular C3 synthesis in rats with passive Heymann nephritis. , 1997, The American journal of pathology.

[10]  Y. Wang,et al.  Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. , 1997, Journal of the American Society of Nephrology : JASN.

[11]  N. Hotta,et al.  The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. , 1997, Journal of the American Society of Nephrology : JASN.

[12]  N. Hotta,et al.  Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. , 1997, The American journal of pathology.

[13]  The Gisen Group Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy , 1997, The Lancet.

[14]  G. Remuzzi,et al.  Understanding the nature of renal disease progression. , 1997, Kidney international.

[15]  C. Caserta,et al.  Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  G. Remuzzi,et al.  Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. , 1996, Experimental nephrology.

[17]  G. Remuzzi,et al.  Glomerular protein trafficking and progression of renal disease to terminal uremia. , 1996, Seminars in nephrology.

[18]  G. Remuzzi,et al.  Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  A. Magil Tubulointerstitial lesions in human membranous glomerulonephritis: relationship to proteinuria. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  Y. Yuzawa,et al.  Localization of the complement regulatory proteins in the normal human kidney. , 1994, Kidney international.

[21]  M. Le Hir,et al.  Characterization and distribution of interstitial cell types in the renal cortex of rats. , 1994, Kidney international.

[22]  V. Della Pietra,et al.  Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. , 1994, Kidney international.

[23]  I. Stamenkovic,et al.  Location of gp330/alpha 2-m receptor-associated protein (alpha 2-MRAP) and its binding sites in kidney: distribution of endogenous alpha 2-MRAP is modified by tissue processing. , 1993, European journal of cell biology.

[24]  G. D'Amico,et al.  Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  C. Alpers,et al.  Renal injury from angiotensin II-mediated hypertension. , 1992, Hypertension.

[26]  M. Wehrmann,et al.  The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. , 1992, Clinical nephrology.

[27]  M. Daha,et al.  Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. , 1991, The Journal of clinical investigation.

[28]  A Bohle,et al.  The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. , 1991, Pathology, research and practice.

[29]  D. Goeddel,et al.  Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES , 1990, Nature.

[30]  G. Schumm,et al.  Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. , 1990, Clinical nephrology.

[31]  G. Remuzzi,et al.  Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. , 1990, The Journal of clinical investigation.

[32]  A. Eddy Interstitial nephritis induced by protein-overload proteinuria. , 1989, The American journal of pathology.

[33]  G. Remuzzi,et al.  Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[34]  C. Ohlschlegel,et al.  Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. , 1989, Clinical nephrology.

[35]  D. Hourcade,et al.  The regulators of complement activation (RCA) gene cluster. , 1989, Advances in immunology.

[36]  B. Brenner,et al.  Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. , 1988, The Journal of clinical investigation.

[37]  S. Mackensen-Haen,et al.  Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[38]  M. Hostetter,et al.  Biochemistry of C3 and related thiolester proteins in infection and inflammation. , 1987, Reviews of infectious diseases.

[39]  G. Remuzzi,et al.  Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. , 1986, Kidney international.

[40]  B. Brenner,et al.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. , 1986, The Journal of clinical investigation.

[41]  D. M. McCarthy,et al.  Renin Secretion by the Spontaneously Diabetic Rat , 1986, Diabetes.

[42]  K. Kawasaki,et al.  Immunoelectron microscopic demonstration of Thy-1 antigen on the surfaces of mesangial cells in the rat glomerulus. , 1986, Nephron.

[43]  B. Brenner,et al.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. , 1985, The Journal of clinical investigation.

[44]  T. Hostetter,et al.  Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. , 1985, The Journal of clinical investigation.

[45]  G. Mazzucco,et al.  In vivo localization of C3 on the brush border of proximal tubules of kidneys from nephrotic patients. , 1985, Clinical nephrology.

[46]  M. Steffes,et al.  Glomerular manifestations of diabetes in the BB rat. , 1983, Metabolism: clinical and experimental.

[47]  B. Brenner,et al.  Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. , 1982, Kidney international.

[48]  G. Camussi,et al.  In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney. , 1982, Journal of immunology.

[49]  D. Northcote,et al.  Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein. , 1981, Analytical biochemistry.

[50]  M. Pangburn,et al.  Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties. , 1981, Biochemistry.

[51]  I. W. Mclean,et al.  PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPY , 1974, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[52]  G. Striker,et al.  Structural-functional correlations in renal disease , 1970 .

[53]  G. Striker,et al.  Structural-functional correlations in renal disease. II. The correlations. , 1970, Human pathology.